Profil
Aaron Vernon worked as VP-Global Supply Chain & Manufacturing at Sucampo Pharmaceuticals, Inc. and as VP-Global Technical Operations & Engineering at Autolus Therapeutics Plc.
He also worked as Vice President-Technical Operations at TCR2 Therapeutics, Inc. from 2021 to 2023.
Mr. Vernon completed his undergraduate degree at the University of Pennsylvania, his graduate degree at Rutgers State University of New Jersey, and his MBA at the University of Maryland.
Ehemalige bekannte Positionen von Aaron Vernon
| Unternehmen | Position | Ende |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | 01.01.2023 |
| SUCAMPO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| AUTOLUS THERAPEUTICS PLC | Corporate Officer/Principal | - |
Ausbildung von Aaron Vernon
| Rutgers State University of New Jersey | Graduate Degree |
| University of Maryland | Masters Business Admin |
| University of Pennsylvania | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
